No Change in Empagliflozin Effect with Metformin

被引：0
|
作者：
Franke, Katharina
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2016年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [21] Empagliflozin/metformin/vildagliptinLack of efficacy and euglycemic diabetic ketoacidosis: case report
    Reactions Weekly, 2021, 1871 (1) : 158 - 158
  • [22] Empagliflozin/metformin/sodium-bicarbonateEuglycemic diabetic ketoacidosis and lack of efficacy
    Reactions Weekly, 2024, 2009 (1) : 241 - 241
  • [23] Empagliflozin/metformin/faricimabHypertensive uveitis and lack of efficacy: 2 case reports
    Reactions Weekly, 2025, 2049 (1) : 147 - 147
  • [24] Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
    Kim, Heeyoung
    Kim, Choon Ok
    Park, Hyeonsoo
    Park, Min Soo
    Kim, Dasohm
    Hong, Taegon
    Shin, Yesong
    Jin, Byung Hak
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2023, 31 (01) : 59 - 68
  • [25] Quality-by-Design Approach for Chromatographic Analysis of Metformin, Empagliflozin and Linagliptin
    Gurrala, Sunitha
    Raj, Shiva
    Subrahmanyam, C. V. S.
    Anumolu, Panikumar Durga
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2022, 60 (01) : 68 - 80
  • [26] Antioxidative Effects of Empagliflozin and Metformin in Type 1 Diabetes Mellitus Patients
    Janic, Miodrag
    Lunder, Mojca
    Sabovic, Miso
    Janez, Andrej
    DIABETES, 2020, 69
  • [27] Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease
    Gharabagh, Laya Hooshmand
    Shargh, Ali
    Azar, Mohammad Reza Mohammad Hosseini
    Esmaeili, Ayda
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (03)
  • [28] Empagliflozin/MetforminAcute kidney injury, metformin associated lactic acidosis and lactic acidosis
    Reactions Weekly, 2023, 1984 (1) : 221 - 221
  • [29] Empagliflozin as add-on to metformin plus sulfonylurea in patients with Type 2 diabetes
    Haering, H. U.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
  • [30] Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes
    Haering, Hans-Ulrich
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (01) : 82 - 90
12345